Repligen Dividends
| RGEN Stock | USD 135.20 1.24 0.91% |
As of the 17th of February 2026, Dividends Paid is likely to grow to about 683.1 M. Also, Dividend Paid And Capex Coverage Ratio is likely to grow to 5.04. Repligen's past performance could be the main factor of why investors trade Repligen stock today. Investors should clearly understand every aspect of the Repligen dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Repligen's dividend schedule and payout information. Repligen dividends can also provide a clue to the current valuation of Repligen.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 650.5 M | 683.1 M | |
| Dividend Paid And Capex Coverage Ratio | 4.80 | 5.04 |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Repligen must own a stock before its ex-dividend date to receive its next dividend.
Repligen Dividends Paid Over Time
Today, most investors in Repligen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Repligen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Repligen dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Will Life Sciences Tools & Services sector continue expanding? Could Repligen diversify its offerings? Factors like these will boost the valuation of Repligen. Anticipated expansion of Repligen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Repligen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.6 | Earnings Share 0.01 | Revenue Per Share | Quarterly Revenue Growth 0.219 | Return On Assets |
Investors evaluate Repligen using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Repligen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Repligen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Repligen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Repligen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Repligen's market price signifies the transaction level at which participants voluntarily complete trades.